Tags

List View
Grid View
Pin View
Map View
  • $0.00
    Despite optimization in donor and recipient human leukocyte antigen (HLA) matching, improvement in immunosuppressive drug therapy, and reduction in intensity conditioning regimens, graft-versus-host disease (GVHD) remains a major complication of allogeneic hematopoietic stem cell transplantation (HSCT).
    Despite optimization in donor and recipient human leukocyte antigen (HLA) matching, improvement in immunosuppressive drug therapy, and reduction in intensity conditioning regimens, graft-versus-host disease (GVHD) remains a major complication of allogeneic hematopoietic stem cell transplantation (HSCT).